The efficacy and safety of TNF inhibitor (golimumab) as salvage treatment in patients with refractory noninfectious uveitis
Crossref DOI link: https://doi.org/10.1007/s10787-022-01019-6
Published Online: 2022-07-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jin, Yi
Lu, Shanshan
Lin, You
Mou, Xiaoyue http://orcid.org/0000-0002-3961-8954
Text and Data Mining valid from 2022-07-08
Version of Record valid from 2022-07-08
Article History
Received: 17 May 2022
Accepted: 10 June 2022
First Online: 8 July 2022
Declarations
:
: The authors have not disclosed any competing interests.